Viewing Study NCT06621810



Ignite Creation Date: 2024-10-26 @ 3:41 PM
Last Modification Date: 2024-10-26 @ 3:41 PM
Study NCT ID: NCT06621810
Status: RECRUITING
Last Update Posted: None
First Post: 2024-09-24

Brief Title: Artificial Intelligence Based Melanoma Early Diagnosis and Risk Prediction in Children Adolescents and Young Adults
Sponsor: None
Organization: None

Study Overview

Official Title: AI-MEL Image Analysis and Machine Learning for Early Diagnosis and Risk Prediction in Children Adolescents and Young Adults
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: AI-MEL
Brief Summary: The goal of this study is to develop supportive diagnostic artificial intelligence algorithms to distinguish melanoma from nevi or other benign pigmented skin lesions especially in younger patients below the age of 30 The main goals it aims to achieve are

development of an algorithm based on dermatoscopic images targeting skin cancer screening in vulnerable populations
development of another algorithm based on histological images intended to be used by pathologists on lesions that are still suspicious of melanoma after dermatologic assessment
implementation of explainability methods to enable the user to better comprehend the systems decisions avoid biases and increase trust in these applications

There is no additional time commitment for the study participants for this study as the data used in this project will be collected in routine clinical practice anyway
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None